Colin Walsh

1.3k total citations
18 papers, 1.1k citations indexed

About

Colin Walsh is a scholar working on Molecular Biology, Immunology and Allergy and Immunology. According to data from OpenAlex, Colin Walsh has authored 18 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Immunology and Allergy and 5 papers in Immunology. Recurrent topics in Colin Walsh's work include Cell Adhesion Molecules Research (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Adenosine and Purinergic Signaling (3 papers). Colin Walsh is often cited by papers focused on Cell Adhesion Molecules Research (8 papers), Protease and Inhibitor Mechanisms (4 papers) and Adenosine and Purinergic Signaling (3 papers). Colin Walsh collaborates with scholars based in United States, Italy and South Korea. Colin Walsh's co-authors include David D. Schlaepfer, Sean Uryu, Ju‐Ock Nam, Alok Tomar, Ssang‐Taek Lim, Xiao Lei Chen, David A. Cheresh, Sara M. Weis, Isabelle Tancioni and Christine Lawson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Cancer Research.

In The Last Decade

Colin Walsh

18 papers receiving 1.1k citations

Peers

Countries citing papers authored by Colin Walsh

Since Specialization

Citations

This map shows the geographic impact of Colin Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Walsh more than expected).

Fields of papers citing papers by Colin Walsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Walsh. The network helps show where Colin Walsh may publish in the future.

Co-authorship network of co-authors of Colin Walsh

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Walsh. A scholar is included among the top collaborators of Colin Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Walsh. Colin Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases 2024 ·Cells ·Colin Walsh, Sha Jin	2
2	Abstract 6411: Discovery of covalent ligands to novel E3 ligases enables bispecific degraders with highly differentiated protein degradation across a broad range of targets 2020 ·Cancer Research ·Kristen A. Baltgalvis, (unknown), Kent T. Symons, Joseph E. Klebba, (unknown), Yuta Naro, Colin Walsh, Joon Chang, Charles W. Chapman, Ali Tabatabaei, Brian E. Nordin, Christie L. Eissler, Joel M. Chick, Landon R. Whitby, (unknown), (unknown), (unknown), Dean Stamos, (unknown), Todd M. Kinsella	1
3	Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor 2019 ·Cancer Research ·Yumi Yokoyama, Erin D. Lew, Ruth Seelige, Elizabeth A. Tindall, Colin Walsh, Patrick Fagan, Jack Y. Lee, (unknown), (unknown), Kathleen D. Tucker, Marissa Chen, (unknown), (unknown), Kristen M. Smith, (unknown), Gary Li, Jack D. Bui	70
4	Antitumor Activity of Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor, in ETV6-NTRK3 –Positive Acute Myeloid Leukemia 2017 ·Molecular Cancer Therapeutics ·Kristen M. Smith, Patrick Fagan, Elena Pomari, Giuseppe Germanò, Chiara Frasson, Colin Walsh, Ian M. Silverman, Paolo Bonvini, Gang Li	33
5	Abstract 5158: Anti-tumor activity of entrectinib, a highly potent pan-TRK, ROS1 and ALK inhibitor, in molecularly defined acute myeloid leukemia 2017 ·Cancer Research ·Patrick Fagan, (unknown), Colin Walsh, Danielle Murphy, Ian M. Silverman, Robert Shoemaker, Wei Ge, Zachary Hornby, Gary Li, Kristen M. Smith	2
6	Abstract 4698: Immuno-oncological efficacy of RXDX-106, a novel, selective and potent small molecule TAM (TYRO3, AXL, MER) inhibitor 2017 ·Cancer Research ·Yumi Yokoyama, Erin D. Lew, Ruth Seelige, Colin Walsh, (unknown), Elizabeth A. Tindall, (unknown), Heather A. Ely, (unknown), (unknown), Jack D. Bui, Gary Li	1
7	Abstract 4191: RXDX-106, a novel, selective and potent small molecule TAM (TYRO3, AXL, MER) inhibitor, demonstrates efficacy in TAM-driven tumors 2017 ·Cancer Research ·Erin D. Lew, Elizabeth A. Tindall, (unknown), Colin Walsh, (unknown), Heather A. Ely, (unknown), Yumi Yokoyama, Gary Li, (unknown)	3
8	Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function 2014 ·The Journal of Cell Biology ·Christine Jean, Xiao Lei Chen, Ju‐Ock Nam, Isabelle Tancioni, Sean Uryu, Christine Lawson, Kristy Ward, Colin Walsh, Nichol Miller, Majid Ghassemian, Patric Turowski, Elisabetta Dejana, Sara M. Weis, David A. Cheresh, David D. Schlaepfer	142
9	VEGF-Induced Vascular Permeability Is Mediated by FAK 2012 ·Developmental Cell ·Xiao Lei Chen, Ju‐Ock Nam, Christine Jean, Christine Lawson, Colin Walsh, Erik T. Goka, Ssang‐Taek Lim, Alok Tomar, Isabelle Tancioni, Sean Uryu, Jun‐Lin Guan, Lisette M. Acevedo, Sara M. Weis, David A. Cheresh, David D. Schlaepfer	268
10	Nuclear-localized focal adhesion kinase regulates inflammatory VCAM-1 expression 2012 ·The Journal of Cell Biology ·Ssang‐Taek Lim, Nichol Miller, Xiao Lei Chen, Isabelle Tancioni, Colin Walsh, Christine Lawson, Sean Uryu, Sara M. Weis, David A. Cheresh, David D. Schlaepfer	82
11	p190RhoGEF (Rgnef) Promotes Colon Carcinoma Tumor Progression via Interaction with Focal Adhesion Kinase 2011 ·Cancer Research ·Honggang Yu, Ju‐Ock Nam, Nichol Miller, Isabelle Tanjoni, Colin Walsh, Lei Shi, Linda Kim, Xiao Lei Chen, Alok Tomar, Ssang‐Taek Lim, David D. Schlaepfer	49
12	Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models 2010 ·Cancer Biology & Therapy ·Colin Walsh, Isabelle Tanjoni, Sean Uryu, Alok Tomar, Ju‐Ock Nam, Hong Luo, (unknown), Neela Patel, Cheni Kwok, Gerald McMahon, Dwayne G. Stupack, David D. Schlaepfer	106
13	PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments 2010 ·Cancer Biology & Therapy ·Isabelle Tanjoni, Colin Walsh, Sean Uryu, Alok Tomar, Ju‐Ock Nam, Ainhoa Mielgo, Ssang‐Taek Lim, Congxin Liang, Marcel Koenig, Neela Patel, Cheni Kwok, Gerald McMahon, Dwayne G. Stupack, David D. Schlaepfer	147
14	Abstract 1204: FAK inhibition selectively promotes tumor cell apoptosis in three-dimensional environments and suppresses tumor cell metastasis 2010 ·Cancer Research ·Isabelle Tanjoni, Colin Walsh, Ju‐Ock Nam, Ssang‐Taek Lim, David D. Schlaepfer	2
15	Phosphatidylinositol 3,4,5-Triphosphate-Dependent Rac Exchanger 1 (P-Rex-1), a Guanine Nucleotide Exchange Factor for Rac, Mediates Angiogenic Responses to Stromal Cell-Derived Factor-1/Chemokine Stromal Cell Derived Factor-1 (SDF-1/CXCL-12) Linked to Rac Activation, Endothelial Cell Migration, and in Vitro Angiogenesis 2009 ·Molecular Pharmacology ·Jorge Carretero-Ortega, Colin Walsh, (unknown), Guadalupe Reyes‐Cruz, Joan Heller Brown, José Vázquez‐Prado	55
16	Quantitative image analysis of intra-tumoral bFGF level as a molecular marker of paclitaxel resistance 2008 ·Journal of Translational Medicine ·Colin Walsh, Yong Wei, M. Guillaume Wientjes, Jessie L.‐S. Au	12
17	Thrombin receptor and RhoA mediate cell proliferation through integrins and cysteine‐rich protein 61 2008 ·The FASEB Journal ·Colin Walsh, Julie Radeff‐Huang, Rosalía Matteo, Albert Hsiao, Shankar Subramaniam, Dwayne G. Stupack, Joan Heller Brown	42
18	Tumor Necrosis Factor-α-stimulated Cell Proliferation Is Mediated through Sphingosine Kinase-dependent Akt Activation and Cyclin D Expression 2006 ·Journal of Biological Chemistry ·Julie Radeff‐Huang, Tammy M. Seasholtz, (unknown), Jeffrey M. Smith, Colin Walsh, Joan Heller Brown	65

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact